SCHEMBL3083307

SCHEMBL3083307

CN(C)CCN(C)c1ccc(-c2c(C=O)nc3ccccn23)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
USP7 Q93009 5/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
KDM4E B2RXH2 4/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.36
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
IRAK4 Q9NWZ3 1/20 0.34
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KCNH2 Q12809 1/20 0.33
ATM Q13315 1/20 0.33
CDK4 P11802 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3089794 0.88 USP7 (0.44) ALDH1A1USP7NPC1RAB9AKDM4E
SCHEMBL3083908 0.81 USP7 (0.41) USP7NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL3082291 0.78 PTGS1 (0.48) ALDH1A1USP7KDM4ESMN1; SMN2HTT
SCHEMBL5384466 0.76 ALDH1A1 (0.41) ALDH1A1USP7NPC1RAB9AKDM4E
SCHEMBL3082054 0.75 USP7 (0.41) ALDH1A1USP7NPC1RAB9AKDM4E
SCHEMBL28570789 0.73 HSP90AA1 (0.47) ALDH1A1USP7NPC1RAB9AKDM4E
SCHEMBL3081815 0.72 CNR2 (0.47) ALDH1A1NPC1RAB9AKDM4EL3MBTL1
SCHEMBL3080789 0.72 FYN (0.48) ALDH1A1KDM4EPOLBMAPTL3MBTL1
SCHEMBL3070139 0.71 KDM4E (0.47) ALDH1A1NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL3084701 0.71 MCHR1 (0.47) ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100227880-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION 2010-09-09 US disclosed
EP-1984375-A2 CHEMICAL COMPOUNDS Smithkline Beecham Corporation (US) 2008-10-29 EP disclosed
WO-2007087548-A9 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2007-09-27 WO disclosed
WO-2007087548-A2 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2007-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100227880-A1 CHEMICAL COMPOUNDS CYP3A5, SLC10A1, ABCB11 ALDH1A1 210/4885USP7 3872/4885NPC1 42/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.